Long-term tablets to help bronchiectasis flare-ups
Part of Lungs & breathing clinical trials.
This trial studies whether long-term Staphylococcus albicans tablets can safely reduce bronchiectasis flare-ups and improve symptoms. It may help people with frequent infections/attacks due to bronchiectasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older with bronchiectasis confirmed on a chest CT scan (HRCT).
- Your bronchiectasis should be idiopathic or caused by a past infection (not cystic fibrosis).
- You need at least 2 flare-ups (acute exacerbations) in the 1 year before starting the study.
- You must not currently be a smoker (still smoking usually excludes).
- You should not have major uncontrolled asthma or COPD, or serious heart, brain/nerve, liver, or kidney disease.
- You should not be pregnant or breastfeeding, and you should be able to take study treatment as required.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
This study tests whether a new tablet called florensocatib can help people with bronchiectasis (a lung disease causing chronic cough and mucus) breathe better and have fewer infections. Bronchiectasis damages the airways, and this medication may help reduce flare-ups by working on the immune system.
This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.
This study looks at how bacteria live in the lungs of people with bronchiectasis and how they may adapt over time. It may help researchers understand why infections keep coming back and how to better manage chronic lung colonization.
This trial tests two different antibiotic treatments for adults with bronchiectasis who have a new or recent infection with Pseudomonas aeruginosa (PA) bacteria in their airways. The goal is to see which regimen works better to clear the infection early.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.